| |
|
DME groups |
P-value* |
| Control |
SDRT |
CME |
SRD |
Combined |
All |
| Patients, n (eyes) |
10 |
27 |
18 |
15 |
16 |
76 |
|
| Age (years) |
61.3±6.4 |
61.8±6.9 |
60.1±11.1 |
58.1±13.3 |
57.3±13.1 |
59.7±10.7 |
0.638 |
| Sex (male/female) |
4/6 |
9/11 |
7/10 |
10/12 |
8/9 |
34/42 |
0.789 |
| Diabetes Duration (years) |
|
8.3±2.4 |
7.3±1.6 |
7.9±2.6 |
9.4±2.8 |
8.2±2.4 |
0.079 |
| Hypertension (yes/no) |
7/3 |
15/12 |
14/4 |
10/5 |
13/3 |
62/14 |
0.393 |
|
| DME: Diabetic Macular Edema; SDRT: Diffuse Retinal Thickening; CME: Cystoid Macular Edema Pattern; SRD: Serous Retinal Detachment; Combined: Combination of CME and SRD.Values shown are the mean ± standard deviation.*Kruskal-Wallis test (among DME groups) or Fisher’s exact test. |
| Table 1: Baseline clinical characteristics of the diabetic macular edema and control group. |
